Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

Nature
K KugiyamaP D Henry

Abstract

Atherosclerosis in animals and humans is associated with an unresponsiveness of arteries and arterioles to endothelium-dependent vasodilators--agents acting on smooth muscle indirectly by stimulating the release from endothelial cells of a vasodilator principle (endothelium-derived relaxing factor). Altered vasomotor regulation in atherosclerosis could partly reflect an injurious action of abnormal lipoproteins on endothelium. Recently, 'cell-modified' or 'oxidized' low-density lipoprotein (EC-LDL) has received increasing attention because of its potential cytotoxic and atherogenic properties. We report here that arteries exposed to EC-LDL in vitro show an endothelium-dependent vasoregulatory impairment closely resembling that of atherosclerotic arteries. Our results indicate that transfer of lysolecithin from EC-LDL to endothelial membranes produces a selective unresponsiveness to receptor-regulated endothelium-dependent vasodilators.

Associated Clinical Trials

References

Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S C TsaiH F Kung
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·T SaitoR J Bing
Jun 1, 1988·The Journal of Clinical Investigation·H YamamotoP D Henry
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S ParthasarathyD Steinberg
Sep 1, 1985·Circulation·P D Henry
Jul 7, 1985·Journal of Theoretical Biology·G A VidaverJ W Lee
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·U P SteinbrecherD Steinberg
Mar 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·T HenriksenD Steinberg

❮ Previous
Next ❯

Citations

Jun 3, 1999·Phytotherapy Research : PTR·N SekiyaK Terasawa
Nov 1, 1991·Clinical Cardiology·U P Steinbrecher
Dec 1, 1992·Clinical Cardiology·F E KuhnC E Rackley
Mar 10, 2001·Diabetes/metabolism Research and Reviews·G H Tomkin, D Owens
Mar 1, 1993·Medicinal Research Reviews·R L JacksonC E Thomas
Nov 1, 1993·Cardiovascular Drugs and Therapy·P RubbaM Mancini
Mar 28, 2003·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Honglian ZhouShu Yu
Jan 19, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Nguyen Dang HungMee Ree Kim
Feb 24, 2001·International Journal of Clinical & Laboratory Research·C EkmekciogluP G Spieckermann
Jun 8, 2002·Current Atherosclerosis Reports·Noriaki Kume, Toru Kita
Feb 3, 2005·Current Atherosclerosis Reports·Jean-Claude Tardif
Jun 1, 1993·Chemico-biological Interactions·M I MacknessP N Durrington
Jun 1, 1996·Atherosclerosis·J E BurchenalJ A Vita
Jan 1, 1992·Molecular Aspects of Medicine·C Rice-Evans, K R Bruckdorfer
Jan 1, 1992·Progress in Lipid Research·S Parthasarathy, S M Rankin
Jan 1, 1995·Progress in Lipid Research·A Tokumura
Oct 1, 1991·Journal of the American College of Cardiology·M NobuyoshiK Kimura
Feb 1, 1994·Journal of the American College of Cardiology·B Y WangJ P Cooke
Nov 1, 1995·Journal of the American College of Cardiology·Y TsurumiS Hosoda

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.